Overview
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. Na dzień 31.12.2025 r. skumulowane straty wyniosły 1 186 961,22 zł i przewyższyły sumę kapitału zapasowego i kapitałów rezerwowych oraz jedną drugą kapitału zakładowego o kwotę 686 961,22 zł. Stosownie do wymogów art. 233 ustawy z dnia 7.12.2023 r. KSH (Dz.U. z 2024 r. poz. 18 z późniejszymi zmianami) Nadzwyczajne Zgromadzenie Wspólników w dniu 6 marca 2026 r. podjęło uchwałę o kontynuowaniu działalności firmy.
From the notes
| Current income tax (CIT due) | $0 | |
| Profit allocation | Loss to be covered | |
| Contingent liabilities | $29,296,062 |
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 66 days for 2022).
- 202513/07/2026
- 202416/07/2025
- 202309/07/2024
- 202219/09/2023
- 202123/05/2022
- 202023/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
National Health Fund (NFZ) contracts
The company has been an NFZ healthcare provider since 2024. In 2025 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 2.51k in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2025 |
|---|---|---|---|
| Pilot programmes | mazowieckie | 1 | USD 0.00 |
Trademarks
The company currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2015.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| APTEKAGOLD.PL (word) | Z.442154 | 3, 5, 10, 35, 44 | Expired | – | |
| AptekaGold | Z.442157 | 3, 5, 10, 35, 44 | Expired | – |
| Mark | Protected until | |
|---|---|---|
| APTEKAGOLD.PL (word) | – | |
| AptekaGold | – |
Authorized Representatives
Manner of representation
If the management board is a multi-member management board, declarations of will on behalf of the company require the joint action of two members of the management board or one member of the management board jointly with a commercial proxy. In the case of a one-person management board, the company is represented by the President of the Management Board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 100 | $270,124.26 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2014-08-28.
41 1090 2590 0000 0001 3005 5307
38 1090 1883 0000 0001 5253 0251
13 1090 2590 0000 0001 3005 5326
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 2,199PLN 2,199 |
Secured liabilities
| Type | Secures | |
|---|---|---|
Registered pledge over movable property and property rights forming part of the enterprise | Loan granted to MEGAFARM SP. Z O.O., repayment of which the Company is jointly and severally liable for |
Public aid
4 public aid cases recorded, with a total value of $188,485.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 17, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Polski Fundusz Rozwoju S.A. | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Cosmedica sp. z o.o. | $49,355,260.75 | cosmedica.pl | ||
| DR Zdrowie S.A. | $40,415,498.47 | drzdrowie.pl | ||
| Magmax S.A. | $4,200,912.15 | magmaxsa.pl | ||
| Novopharm - Miller sp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Maglow S.A. | $1,356,219.12 | maglow.pl | ||
| Farmacja Im. O. Klimuszki sp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Nuklover sp. z o.o. | $227,479.26 | nuklover.com | ||
| Massmed sp. z o.o. | $49,747.70 | mojoapps.co | ||
| DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w Warszawie S.A. | $2,740.83 | kwendasa.pl | ||
| Femaherb sp. z o.o. | $655.76 | femaherb.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-08-11 | PKD change (Removed: 4 codes; Added: 4 codes) | |
| 2023-09-22 | Address change (Ul. Jana III Sobieskiego 1, 44-200, Rybnik → Ul. Żwirki I Wigury 16a/Biuro 315, 02-092, Warszawa) | |
| 2023-09-22 | PKD change (Removed: 58.14.Z; Added: 47.29.Z) | |
| 2022-09-14 | Address change (Ul. Pokorna 2/U03, 00-199, Warszawa → Ul. Jana III Sobieskiego 1, 44-200, Rybnik) | |
| 2022-09-14 | PKD change (Removed: 6 codes; Added: 6 codes) |
FAQ
Last updated: 2026-10-07